
Psychiatr News October 6, 2006
Volume 41, Number 19, page 17
© 2006 American Psychiatric Association
Beneficiaries Can Delay Fall Into Medicare's `Donut Hole'
Mark Moran
Increased use of generic drugs and mail-service pharmacies has the
potential to delay entry into the dreaded Medicare Part D coverage gap by more
than two months and save more than $1,200.
Medicare patients with Alzheimer's disease who use generics and
mail-service pharmacies can potentially add an additional 13 days to their
Medicare Part D coverage and delay entry into the Medicare Part D coverage
gap, or "donut hole."
That was one finding from an analysis of the effect of generic-drug use on
prescription drug costs for patients with five common conditions. The analysis
was performed by the Pharmaceutical Care Management Association (PCMA).
PCMA is the national association representing the nation's pharmacy benefit
managers.
The donut hole refers to the gap in coverage between $2,250 and $3,600 in
yearly expenses for prescription drugs. Under the Medicare Modernization Act
of 2003, a beneficiary may not be covered for prescription drug costs beyond
$2,250 in one year; once costs reach $3,600, coverage begins again.
Not all Medicare Part D prescription drug plans have a donut hole, however.
The Centers for Medicare and Medicaid Services reported in August that 28
percent of individuals enrolled in Medicare Part D are in plans that have a
coverage gap. Thus, the majority of Part D beneficiaries are not subject to
the donut hole.
For patients with Alzheimer's, the total out-of-pocket savings by using
generics and mail-order services would be relatively small at $38, or only 1
percent (see table). Part of the reason for the relatively small savings in
this category is that there are very few generic alternatives, according to
PCMA
But PCMA found that overall, increased use of generic drugs and
mail-service pharmacies by Medicare beneficiaries has the potential to delay
entry into the Medicare Part D coverage gap by an average of 74
days.
"Regrettably, too many beneficiaries are not taking full advantage of
the cost-saving tools within their Medicare drug plans," said PCMA
President Mark Merritt in a statement accompanying release of the analysis.
"All stakeholders need to work together to make beneficiaries better
aware of how to maximize their Medicare prescription drug coverage, including
increased use of generics and mail-service pharmacies."
In the analysis, PCMA assembled five patient profiles using both brand-name
and generic drugs to treat five primary conditions and assorted related
conditions. The conditions were high-blood pressure, diabetes, heart disease,
chronic obstructive pulmonary disease, and Alzheimer's disease.
PCMA examined four national Medicare prescription drug plans that provide
coverage to more than 50 percent of Medicare's prescription drug plan
beneficiaries.
On average, beneficiaries can save in total about 38 percentor more
than $1,200 in 2006in out-of-pocket costs through the increased use of
generic drugs and mail-service pharmacies.
Additional days of coverage and costs saved for the other four conditions,
according to analysis, are as follows:
- High-blood pressure. Sixty-one additional days of Part D drug
coverage, with total out-of-pocket savings of $1,226, or about 36 percent.
- Diabetes and other related conditions. An additional 157 days of
Part D drug coverage, with total out-of-pocket savings of $2,081, or about 57
percent.
- Heart disease and other related conditions. An additional 76 days of
Part D drug coverage, with total out-of-pocket savings of $1,221, or about 57
percent. For this profile, patients would avoid entering the donut hole
altogether, according PCMA.
- Chronic obstructive pulmonary disease and other related conditions.
An additional 65 days of Part D drug coverage, with total out-of-pocket
savings of $1,504, or about 42 percent.
A report of the PCMA analysis and methodology is posted at
<www.pcmanet.org/newsroom/index.htm>.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|